Cue Biopharma, .

Cue Biopharma, .Cue Biopharma, .
Cue Biopharma, .

Cue Biopharma, .

Developing engineered biologics to harness the immune system for disease treatment.

DR 342017Active38Boston, United States
Rate

About

Cue Biopharma is developing a novel class of engineered biologics that leverage the body's own immune system to treat a range of diseases. Their platform is designed to mimic natural biological signals, enabling the selective expansion and activation of specific immune cells, offering a targeted approach to immunotherapy.
Frequently asked

What does Cue Biopharma, . do?

Cue Biopharma is developing a novel class of engineered biologics that leverage the body's own immune system to treat a range of diseases. Their platform is designed to mimic natural biological signals, enabling the selective expansion and activation of specific immune cells, offering a targeted approach to immunotherapy.

What is Cue Biopharma, .'s revenue?

StartupHub estimates Cue Biopharma, .'s annual revenue at $5.1M (range $2.7M to $9.4M, 66% confidence), based on comparable companies in the sector.

What is Cue Biopharma, .'s valuation?

StartupHub estimates Cue Biopharma, .'s effective valuation at $39.9M (range $25.0M to $60.0M, 10% confidence), based on comparable companies in the sector.

How much funding has Cue Biopharma, . raised?

Cue Biopharma, . has raised a total of $10M in funding. The most recent round on record is Seed.

Where is Cue Biopharma, . headquartered?

Cue Biopharma, . is headquartered in Boston, United States.

When was Cue Biopharma, . founded?

Cue Biopharma, . was founded in 2017.

What industry does Cue Biopharma, . operate in?

Cue Biopharma, . operates in Biotech, Drug Discovery, Immunotherapy, Therapeutics, Biologics, Immune System.

How many employees does Cue Biopharma, . have?

Cue Biopharma, . has approximately 38 people on record.

HEADCOUNT
38
DOMAIN RATING
34
Comments

No comments yet. Be the first to share your take.